Drug class

Non-Nitrate Coronary Vasodilators

"Non-nitrate coronary vasodilators" is a descriptive, heterogeneous pharmacological category rather than a single standardized regulatory drug class. Read more about Non-Nitrate Coronary Vasodilators

29 drugs in this class 23 manufacturers

Advertisement

Drugs in Non-Nitrate Coronary Vasodilators

Showing 10–18 of 29 drugs

REGADENOSON

NON-NITRATE CORONARY VASODILATORS · MYOCARDIAL PERFUSION IMAGE, ADJUNCT
DR.REDDY'S LAB

REGADENOSON

NON-NITRATE CORONARY VASODILATORS · MYOCARDIAL PERFUSION IMAGE, ADJUNCT
EUGIA US LLC

REGADENOSON

NON-NITRATE CORONARY VASODILATORS · MYOCARDIAL PERFUSION IMAGE, ADJUNCT
APOTEX CORP

DIPYRIDAMOLE

ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW · THROMBOEMBOLISM DUE TO PROSTHETIC HEART VALVES
PROFICIENT RX L
Filter & compare in the drug finder → Opens the drug finder with Non-Nitrate Coronary Vasodilators preselected. Add indication or manufacturer filters there.

About Non-Nitrate Coronary Vasodilators.

"Non-nitrate coronary vasodilators" is a descriptive, heterogeneous pharmacological category rather than a single standardized regulatory drug class.

These agents promote coronary artery dilation and enhance myocardial perfusion through mechanisms independent of nitric oxide donation, primarily including calcium channel blockers like diltiazem and verapamil, adenosine receptor agonists such as dipyridamole, and direct arteriolar relaxants.

By reducing coronary vascular resistance and lowering myocardial wall tension or oxygen demand, they counteract ischemia and suppress vascular spasm.

Clinically, medications in this grouping are predominantly utilized in the prevention and management of chronic stable angina, vasospastic (Prinzmetal) angina, and as pharmacological stress agents during myocardial perfusion imaging.